CDK8 is a colorectal cancer oncogene that regulates β-catenin activity-Reference-Cited by-同舟云学术

CDK8 is a colorectal cancer oncogene that regulates β-catenin activity

Published:2008-09 Issue:7212 Volume:455 Page:547-551
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Firestein Ron,Bass Adam J.,Kim So Young,Dunn Ian F.,Silver Serena J.,Guney Isil,Freed Ellen,Ligon Azra H.,Vena Natalie,Ogino Shuji,Chheda Milan G.,Tamayo Pablo,Finn Stephen,Shrestha Yashaswi,Boehm Jesse S.,Jain Supriya,Bojarski Emeric,Mermel Craig,Barretina Jordi,Chan Jennifer A.,Baselga Jose,Tabernero Josep,Root David E.,Fuchs Charles S.,Loda Massimo,Shivdasani Ramesh A.,Meyerson Matthew,Hahn William C.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature07179.pdf

Reference33 articles.

1. Bienz, M. & Clevers, H. Linking colorectal cancer to Wnt signaling. Cell 103, 311–320 (2000)

2. Camp, R. L., Chung, G. G. & Rimm, D. L. Automated subcellular localization and quantification of protein expression in tissue microarrays. Nature Med. 8, 1323–1327 (2002)

3. Vogelstein, B. et al. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 319, 525–532 (1988)

4. Conaway, R. C., Sato, S., Tomomori-Sato, C., Yao, T. & Conaway, J. W. The mammalian Mediator complex and its role in transcriptional regulation. Trends Biochem. Sci. 30, 250–255 (2005)

5. Smith, G. et al. Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal cancer. Proc. Natl Acad. Sci. USA 99, 9433–9438 (2002)

Cited by 579 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The solution structure of macrocyclic glecaprevir and its conformational adaptation mechanism towards antitumor targets;Journal of Molecular Structure;2025-02

2. Cellular and molecular events in colorectal cancer: biological mechanisms, cell death pathways, drug resistance and signalling network interactions;Discover Oncology;2024-07-20

3. Structural basis of the human transcriptional Mediator complex modulated by its dissociable Kinase module;2024-07-03

4. PLD1 is a key player in cancer stemness and chemoresistance: Therapeutic targeting of cross-talk between the PI3K/Akt and Wnt/β-catenin pathways;Experimental & Molecular Medicine;2024-07-01

5. Exploration of Potential Cyclin-dependent Kinases and their Inhibitors to Combat Abnormal Signalling and Cancer;Current Signal Transduction Therapy;2024-07